Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: "We Have To Run Such A Ridiculous Gauntlet Next Week"

Companies have barely managed to eke out positive earnings growth so far this season, but the big test arrives in the week ahead......»»

Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market strength. read more.....»»

U.S. stock-index futures trade mixed Thursday morning—the busiest day of the earnings season—a da.....»»

Like most companies this earnings season, it will hardly be news if Apple, Inc. (NASDAQ: AAPL) reports earnings this week that its quarter was a rough and tumble one. The likelihood of bad news has been widely reported about the Cupertino gia.....»»

Amazon.com, a big beneficiary of the coronavirus outbreak, is set to release its first-quarter financial results later this week. Analysts are offering their two cents before the report comes out......»»

3M, Apple and Amazon will dominate the week's earnings......»»

3M, Apple and Amazon will dominate the week's earnings......»»

"This earnings week is "chock full of tech stocks, including some household names that have run up substantially from their March lows," the "Mad Money" host said......»»

Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17. read more.....»»

CNBC's Jim Cramer marked 15 years of "Mad Money." Besides celebrating the milestone, the host got down to business to preview the week ahead of corporate earnings with the backdrop of the coronavirus outbreak......»»

"Pay attention to what these companies have to say next week, but don't forget that at least for the moment — COVID-19 is in the driver's seat," CNBC's Jim Cramer said......»»

CNBC's Jim Cramer gave a preview of the corporate earnings and economic data that he has circled on his calendar next week......»»

CNBC's Jim Cramer previews the week ahead in earnings reports. He breaks down the concept of visibility and why it's making a comeback on Wall Street......»»

"Until the outbreak burns itself out, the corona statistics, and not earnings, will continue to control the day-to-day action," "Mad Money" host Jim Cramer says......»»

CNBC's Jim Cramer gives a preview of what he's looking for in corporate earnings reports in the coming week......»»

The economic impact of the coronavirus will be a common thread running through another busy week of quarterly earnings reports, "Mad Money" host Jim Cramer said......»»

CNBC's Jim Cramer looks ahead at next week's busy earnings schedule and discusses how the uncertainty around the coronavirus impacts investors......»»

Biotech stocks haven't seen much of a momentum thus far in the new year amid a lack of meaningful catalysts. The bygone week saw two FDA approvals: Horizon.....»»

Biotech stocks haven't seen much of a momentum thus far in the new year amid a lack of meaningful catalysts. 0 read more.....»»

High-quality stocks — unrelated to China or travel — that get hurt on coronavirus fears are worth pouncing on, CNBC's Jim Cramer says......»»